Ernexa Therapeutics Inc. (ERNA) › Total LiabilitiesErnexa Therapeutics Inc. (ERNA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $3.66M2011: $5.30M2012: $4.76M2013: $6.25M2014: $11.34M2015: $12.56M2016: $12.63M2017: $11.03M2018: $7.95M2019: $9.03M2020: $5.25M2021: $6.02M2022: $10.17M2023: $46.90M2024: $3.57M2025: $3.43M$3.43M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$3.43M-3.8%2024$3.57M-92.4%2023$46.90M+361.1%2022$10.17M+68.9%2021$6.02M+14.8%2020$5.25M-41.9%2019$9.03M+13.7%2018$7.95M-28.0%2017$11.03M-12.6%2016$12.63M+0.5%2015$12.56M+10.7%2014$11.34M+81.4%2013$6.25M+31.4%2012$4.76M-10.1%2011$5.30M+44.6%2010$3.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share